Posted:
9/19/2024, 11:57:51 AM
Location(s):
California, United States ⋅ Pasadena, California, United States ⋅ San Diego, California, United States
Experience Level(s):
Senior
Field(s):
Medical, Clinical & Veterinary
Arrowhead Pharmaceuticals, Inc. (Nasdaq: ARWR) is a clinical stage biopharmaceutical company that develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.
Arrowhead is focused on developing innovative drugs for diseases with a genetic basis, typically characterized by the overproduction of one or more proteins that are involved with disease. The depth and versatility of our RNAi technologies enables us to potentially address conditions in virtually any therapeutic area and pursue disease targets that are not otherwise addressable by small molecules and biologics. Arrowhead is leading the field in bringing the promise of RNAi to address diseases outside of the liver, and our clinical pipeline includes disease targets in the liver and lung with a promising pipeline of preclinical candidates.
Arrowhead’s corporate headquarters is in Pasadena, CA with research and development teams in Madison, WI and San Diego, CA. Our employees are nimble, science-driven innovators who are collaborating to bring new therapies to patients in need.
The Position
The Associate Medical Director/Medical Director will report to the head of cardiometabolic clinical development and will be instrumental in bringing important new therapies based on RNA interference to patients. This individual will work collaboratively with Arrowhead’s scientific and clinical teams to take drugs from late clinical research to NDA filings and will initially focus on siRNA programs targeting cardiac and metabolic (lipids and obesity) indications. Experience in these areas is encouraged but not required. S/he will take hands on responsibility for designing and managing clinical studies to evaluate the efficacy, safety, dose selection and clinical pharmacology of product candidates. Candidates with the requisite experience may be considered for a Medical Director title.
Responsibilities
Requirements:
Preferred:
Arrowhead provides competitive salaries and an excellent benefit package.
All applicants must have authorization to work in the US for a company.
Website: https://arrowheadpharma.com/
Headquarter Location: Pasadena, California, United States
Employee Count: 251-500
Year Founded: 1989
IPO Status: Public
Last Funding Type: Post-IPO Equity
Industries: Biotechnology ⋅ Health Care ⋅ Nanotechnology ⋅ Pharmaceutical